Thrombopoietic agents for the treatment of persistent and chronic immune thrombocytopenia in children Academic Article uri icon

Overview

MeSH Major

  • Benzoates
  • Hydrazines
  • Purpura, Thrombocytopenic, Idiopathic
  • Pyrazoles
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin

abstract

  • Retrospective analysis of off-study use of TPO agents in children with mainly chronic ITP showed increases in platelet counts in more than 4 of 5 children. The long-term use of TPO agents, up to 53 months, without tachyphylaxis supports their efficacy. These agents appear safe, effective, and tolerable in children with chronic ITP.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jpeds.2014.03.060

PubMed ID

  • 24857517

Additional Document Info

start page

  • 600

end page

  • 5.e4

volume

  • 165

number

  • 3